Scientific Advisory Board of experts in drug delivery, pain management, clinical trials, pharmacokinetics.

Charlotte P. Clark, CEO, Director, Founder

  • Co-founder of 4 life science companies
    • Medical Innovations (medical device)
    • Cygnus Therapeutics (drug delivery)
    • Pangene Corporation (gene therapy)
    • Nereus Pharmaceuticals (sourcing new molecules from the ocean)
  • More than 20 years’ operating experience in finance and business development (early stage licensing)
  • Venture Investor (POSCO BioVentures)
    • Acorda Therapeutics ($900 million market cap)
    • PTC Therapeutics ($830 million market cap)
    • Infinity Pharmaceuticals ($48 million market cap)
  • Board Member (Accera, Emergent Respiratory Systems)
  • Board Observer (GeneOhm, Cell Biosciences, Transmedics)

Samir D. Roy, Ph.D., CSO, Director, Founder

  • An acknowledged expert in topical and transdermal drug delivery, formulation and clinical pharmacokinetics
  • Senior executive in several life science companies, including Amneal Pharmaceuticals, New River Pharmaceuticals, Actavis, Insite Vision, Agouron, Syntex and Cygnus
  • Authored more than 25 publications
  • 12 patents
  • University of Michigan Post-Doc;  PhD University of Saskatchewan

Gary R. Hooper, Director

  • Biotechnology veteran – started at Genentech in 1980
  • Senior executive in several drug delivery companies, including Cygnus (VP, BD), Pharmetrix (CEO), Pharma Patch (COO)
  • CEO of Ciblex Corp (cancer and inflammatory disease)
  • VP BD at Genencor, working on convergence with high tech
  • Director of Accera, Joint Venture: Silicon Valley Networks, Sutter Health, Venture Partner at Velocity Ventures, Licensing Executives Society
  • MBA USC, MS in Marketing San Jose State

Kenneth J. Colley, M.D., Ph.D.

  • Expert in translational medicine, pharmacology and clinical development of new therapeutic products.
  • Accomplished physician-scientist-entrepreneur with two decades experience in the Biotech/Medtech industry.
  • Served as Medical Director for several therapeutics companies, including recently Theravance for neuro and pain trials, and Diadexus, Medlogics Device and Angiogenix in the cardio space.
  • Integrative health practitioner, with sports med/regenerative med practice (ongoing) and pain clinic (2009 – 2014).
  • M.D./Ph.D. Georgetown University, B.S. Stanford University

Bhasker V. Shetty, Ph.D.

  • Served as Vice President of Pharmacokinetics, Dynamics and Metabolism at Pfizer Worldwide R&D, La Jolla, CA
  • Joined Agouron Pharmaceuticals in 1990, and was a key leader of the company and post-acquisitions in Warner-Lambert and subsequently Pfizer, Inc.
  • Served on the Board of Directors of BIOCOM, CONNECT and Project Concern International, and continues to be active in San Diego’s scientific community
  • Ph.D. in Pharmaceutical Sciences, University of Missouri, Kansas City, and his post doc in Pharmaceutical Chemistry at the University of Kansas. He received his Bachelor of Pharmacy degree from the College of Pharmaceutical Sciences, Manipal, India